Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE: Erenumab in Migraine Prevention
NCT02456740Phase 3Completed
- Sponsor
- Amgen
- Start
- Jul 2015
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 3 trial of erenumab in migraine, sponsored by Amgen. Started Jul 2015; status: completed.
02
Drugs
erenumab
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02456740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456740.